Global Laryngeal Cancer Therapeutics Market Outlook 2019-2023: Anticipating a CAGR of More Than 7% by 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 9, 2019--The “Global Laryngeal Cancer Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The laryngeal cancer therapeutics market will register a CAGR of over 7% by 2023.
The increasing number of reimbursement programs is one of the key factors expected to boost the laryngeal cancer therapeutics market growth in the forthcoming years.
Various governments and vendors are launching patient assistance programs for reducing the high-cost burden associated with the treatment using therapeutics and providing the treatment at an affordable price. As a result, increasing number of patient assistance programs will lead the laryngeal cancer therapeutics market growth during the forecast period.
A growing number of strategic alliances
The increasing number of strategic alliances among vendors is expected to result in the launch of more advanced therapies and quicker approval. The laryngeal cancer therapeutics market has witnessed strategic alliance for the development of commercialization of drugs for the treatment of laryngeal cancer. This will drive the growth of the market during the forecast period.
Clinical trial failures
The heavy cost involved in recruiting patients for trials and the high cost of the drug cause a significant loss to vendors when a clinical trial fail. Hence, these clinical trial failures are expected to pose a threat to the market growth during the forecast period.
The market appears to be concentrated with the presence of a few market players. Several organizations are focusing on raising awareness about the head and neck cancer also provides funding for drugs and therapeutics for the treatment and cure of laryngeal cancer.
This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/u060bx
View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005485/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/09/2019 07:35 AM/DISC: 05/09/2019 07:35 AM